These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37047624)

  • 1. Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer Treatment.
    Ahmad I; Hoque M; Alam SSM; Zughaibi TA; Tabrez S
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
    Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
    Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy.
    Tewari D; Patni P; Bishayee A; Sah AN; Bishayee A
    Semin Cancer Biol; 2022 May; 80():1-17. PubMed ID: 31866476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin inhibits high glucose‑induced inflammatory injury in human retinal pigment epithelial cells through the ROS‑PI3K/AKT/mTOR signaling pathway.
    Ran Z; Zhang Y; Wen X; Ma J
    Mol Med Rep; 2019 Feb; 19(2):1024-1031. PubMed ID: 30569107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer.
    Li X; Liu H; Lv C; Du J; Lian F; Zhang S; Wang Z; Zeng Y
    Biomed Res Int; 2022; 2022():9304552. PubMed ID: 35402614
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
    Polivka J; Janku F
    Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models.
    von Achenbach C; Weller M; Kaulich K; Gramatzki D; Zacher A; Fabbro D; Reifenberger G; Szabó E
    J Neurochem; 2020 May; 153(4):510-524. PubMed ID: 31618458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells.
    Wang F; Wang Q; Zhou ZW; Yu SN; Pan ST; He ZX; Zhang X; Wang D; Yang YX; Yang T; Sun T; Li M; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():537-60. PubMed ID: 25632222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic anticancer effects of everolimus (RAD001) and Rhein on gastric cancer cells via phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway.
    Gao F; Li R; Wei PF; Ou L; Li M; Bai Y; Luo WJ; Fan Z
    Bioengineered; 2022 Mar; 13(3):6332-6342. PubMed ID: 35209807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulatory effect of curcumin on survival of irradiated human intestinal microvascular endothelial cells: role of Akt/mTOR and NF-{kappa}B.
    Rafiee P; Binion DG; Wellner M; Behmaram B; Floer M; Mitton E; Nie L; Zhang Z; Otterson MF
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G865-77. PubMed ID: 20299603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton.
    Zhang C; Yang N; Yang CH; Ding HS; Luo C; Zhang Y; Wu MJ; Zhang XW; Shen X; Jiang HL; Meng LH; Ding J
    PLoS One; 2009; 4(3):e4881. PubMed ID: 19293927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of mTOR Signaling as a Therapeutic Target in Cancer.
    Popova NV; Jücker M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway.
    Muhanmode Y; Wen MK; Maitinuri A; Shen G
    Hum Exp Toxicol; 2022; 41():9603271221095929. PubMed ID: 35722665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway.
    Burris HA
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):829-42. PubMed ID: 23377372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
    Xu ZZ; Xia ZG; Wang AH; Wang WF; Liu ZY; Chen LY; Li JM
    Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer.
    Bitting RL; Armstrong AJ
    Endocr Relat Cancer; 2013 Jun; 20(3):R83-99. PubMed ID: 23456430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K/AKT/mTOR and HIF-1/VEGF cascade.
    He Y; Wang H; Lin S; Chen T; Chang D; Sun Y; Wang C; Liu Y; Lu Y; Song J; Li S; Xu W; Lin Y; Zheng Y; Zhou X; Huang Q; Huang M
    Biomed Pharmacother; 2023 Sep; 165():115279. PubMed ID: 37544281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytochemicals as PI3K/ Akt/ mTOR Inhibitors and Their Role in Breast Cancer Treatment.
    Narayanankutty A
    Recent Pat Anticancer Drug Discov; 2020; 15(3):188-199. PubMed ID: 32914720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits urothelial tumor development by suppressing IGF2 and IGF2-mediated PI3K/AKT/mTOR signaling pathway.
    Tian B; Zhao Y; Liang T; Ye X; Li Z; Yan D; Fu Q; Li Y
    J Drug Target; 2017 Aug; 25(7):626-636. PubMed ID: 28286973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition.
    Jampasri S; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
    Molecules; 2022 Sep; 27(17):. PubMed ID: 36080483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.